Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa

INTRODUCTION: Dolutegravir has replaced efavirenz in most low‐ and middle‐income countries, due to better tolerability and formidable resistance profile, but dolutegravir side effects suggest alternatives are needed. We evaluated doravirine resistance in South Africa as a first step to assess whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Steegen, Kim, Moorhouse, Michelle, Wensing, Annemarie MJ, Venter, Willem DF, Hans, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094661/
https://www.ncbi.nlm.nih.gov/pubmed/33943000
http://dx.doi.org/10.1002/jia2.25706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094661/
https://www.ncbi.nlm.nih.gov/pubmed/33943000
http://dx.doi.org/10.1002/jia2.25706

Ejemplares similares